![Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference - Kidney International Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f12e7c82-c157-4ab2-8c9b-ce1449f4018c/fx1_lrg.jpg)
Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference - Kidney International
![Frontiers | Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood Frontiers | Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood](https://www.frontiersin.org/files/Articles/506433/fped-08-00205-HTML/image_m/fped-08-00205-t001.jpg)
Frontiers | Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood
![Glomerular Diseases: Emerging Tests and Therapies for IgA Nephropathy | American Society of Nephrology Glomerular Diseases: Emerging Tests and Therapies for IgA Nephropathy | American Society of Nephrology](https://cjasn.asnjournals.org/content/9/3/617/F1.large.jpg)
Glomerular Diseases: Emerging Tests and Therapies for IgA Nephropathy | American Society of Nephrology
![JCM | Free Full-Text | An Update on the Current State of Management and Clinical Trials for IgA Nephropathy | HTML JCM | Free Full-Text | An Update on the Current State of Management and Clinical Trials for IgA Nephropathy | HTML](https://www.mdpi.com/jcm/jcm-10-02493/article_deploy/html/images/jcm-10-02493-g001.png)
JCM | Free Full-Text | An Update on the Current State of Management and Clinical Trials for IgA Nephropathy | HTML
![Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy | American Society of Nephrology Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/32/2/436/F1.large.jpg?width=800&height=600&carousel=1)
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy | American Society of Nephrology
![Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis | Scientific Reports Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-09393-w/MediaObjects/41598_2017_9393_Fig1_HTML.jpg)
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis | Scientific Reports
![Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool - Kidney International Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/39f113e3-4e57-4b5c-8b10-e042ac9dd567/fx1.jpg)
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool - Kidney International
![Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors | Scientific Reports Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-68087-y/MediaObjects/41598_2020_68087_Fig1_HTML.png)